WRF
CCXI

Waddell & Reed Financial’s ChemoCentryx, Inc. CCXI Stock Holding History

Waddell & Reed Financial’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$3.6M Sell
70,289
-10,252
-13% -$617K 0.01% 447
2020
Q4 		$4.99M Buy
80,541
+606
+0.8% +$34.7K 0.01% 438
2020
Q3 		$4.38M Buy
+79,935
New +$4.3M 0.01% 430

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Waddell & Reed Financial's CCXI Position: Q1 2021 in Review

Waddell & Reed Financial reduced its ChemoCentryx, Inc. (CCXI) stake by 13% in Q1 2021, selling an estimated $617K and leaving 70,289 shares worth $3.6M. The position accounts for 0.01% of the portfolio, ranked #447.

Waddell & Reed Financial first reported a position in CCXI in Q3 2020 and has held it in 3 quarters since. The position peaked at $4.99M in Q4 2020. 183 funds tracked by Wall St. Rank hold CCXI as of Q1 2021.

  • Waddell & Reed Financial held 70,289 shares of ChemoCentryx, Inc. worth $3.6M as of Q1 2021.
  • Waddell & Reed Financial sold 10,252 ChemoCentryx, Inc. shares in Q1 2021, an estimated $617K.
  • ChemoCentryx, Inc. made up 0.01% of Waddell & Reed Financial's portfolio in Q1 2021, its #447 holding.
  • Waddell & Reed Financial first reported a position in ChemoCentryx, Inc. in Q3 2020 and has held it in 3 quarters since.
  • Waddell & Reed Financial's ChemoCentryx, Inc. position peaked at $4.99M in Q4 2020.
  • 183 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q1 2021.

Based on Waddell & Reed Financial's 13F filing for Q1 2021, filed 12 May 2021.